A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years ...

The UAB Department of Radiation Oncology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...

She discussed radiation therapy as a possible option for patients with hepatocellular carcinoma (HCC). Specifically, stereotactic body radiation therapy (SBRT) before Nexavar (sorafenib) improved ...

Stereotactic body radiation therapy (SBRT ... pursued SBRT for the treatment of early stage non-small-cell lung cancer, lung and liver oligometastases and spinal metastases.

Glioblastoma often kills within months. A new targeted radiation therapy may help patients live longer. When you purchase through links on our site, we may earn an affiliate commission.

To summarize, a CD73-directed immunotherapy could drive a palette of resident non-immune cells as well as immune cells in the irradiated lung towards an inflammatory phenotype or signaling that might ...

Background: The debate regarding the accuracy of radiobiological models for local control (LC) prediction in lung cancer patients undergoing stereotactic body radiation therapy (SBRT) remains ...

Immunotherapy drug pembrolizumab (Keytruda) may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy ...